Healthcare & Life Sciences
Specific Diagnostics
acquiredacquired
acquired
Stage
1
Investors
About
Specific Diagnostics utilizes unique sensor technology to enable rapid, cost-effective, high throughput clinical microbiology diagnostic products, starting with the Reveal rapid susceptibility test platform.
Explore Specific Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.